CONTI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 6.846
EU - Europa 6.008
AS - Asia 3.501
SA - Sud America 327
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 5
Totale 16.751
Nazione #
US - Stati Uniti d'America 6.659
CN - Cina 1.822
SG - Singapore 1.387
IE - Irlanda 1.075
DE - Germania 947
UA - Ucraina 848
FI - Finlandia 819
SE - Svezia 819
IT - Italia 651
NL - Olanda 296
BR - Brasile 287
CA - Canada 177
TR - Turchia 169
AT - Austria 162
RU - Federazione Russa 109
GB - Regno Unito 94
FR - Francia 76
BE - Belgio 43
IN - India 23
CZ - Repubblica Ceca 18
ES - Italia 16
ID - Indonesia 15
JP - Giappone 13
AR - Argentina 12
EU - Europa 12
EC - Ecuador 10
EG - Egitto 10
IL - Israele 10
CI - Costa d'Avorio 9
HK - Hong Kong 8
MA - Marocco 7
PK - Pakistan 7
CO - Colombia 6
IQ - Iraq 6
MX - Messico 6
BD - Bangladesh 5
BJ - Benin 5
LT - Lituania 5
RO - Romania 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
CH - Svizzera 4
KE - Kenya 4
PS - Palestinian Territory 4
PY - Paraguay 4
LU - Lussemburgo 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
PL - Polonia 3
VE - Venezuela 3
ZW - Zimbabwe 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BO - Bolivia 2
EE - Estonia 2
HU - Ungheria 2
KR - Corea 2
LV - Lettonia 2
NO - Norvegia 2
PR - Porto Rico 2
SN - Senegal 2
TG - Togo 2
VN - Vietnam 2
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
GY - Guiana 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MY - Malesia 1
NI - Nicaragua 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 16.751
Città #
Dublin 1.065
Jacksonville 968
Chandler 885
Singapore 783
Santa Clara 488
Ashburn 452
Beijing 444
Dearborn 403
Nanjing 337
Ann Arbor 332
Boardman 327
Bremen 260
Princeton 259
San Mateo 248
Parma 212
Vienna 157
Toronto 151
Helsinki 149
Izmir 147
Wilmington 135
Des Moines 118
New York 116
Shanghai 112
Shenyang 112
Munich 101
Kunming 94
Hebei 93
Moscow 93
Hefei 91
Nanchang 86
Jinan 65
Woodbridge 58
Marseille 53
Grafing 51
Seattle 49
Düsseldorf 45
Brussels 41
Changsha 41
Jiaxing 35
Tianjin 35
Guangzhou 33
Los Angeles 33
Council Bluffs 30
Milan 30
Fremont 28
Houston 24
Norwalk 24
Hangzhou 21
Zhengzhou 21
Dallas 16
São Paulo 16
Reggio Nell'emilia 15
Borås 14
Frankfurt am Main 14
The Dalles 14
Jakarta 13
Modena 13
Nuremberg 13
Fuzhou 12
Redwood City 12
Washington 12
Nakano 11
Ottawa 11
Verona 11
Chengdu 10
Haikou 10
Kocaeli 10
Porto Alegre 10
Wuhan 10
Abidjan 9
Amsterdam 9
Fairfield 9
Falls Church 9
Auburn Hills 8
Rio de Janeiro 8
Rome 8
Shaoxing 8
Wenzhou 8
Bilbao 7
Cairo 7
Edinburgh 7
London 7
Ningbo 7
Pune 7
Quito 7
Redmond 7
Rockville 7
Baotou 6
Belo Horizonte 6
Brasília 6
Campinas 6
Chongqing 6
Florence 6
Hong Kong 6
Istanbul 6
Neviano degli Arduini 6
Scottsdale 6
Taiyuan 6
Taizhou 6
Xian 6
Totale 10.399
Nome #
A transphyletic anti-infectious control strategy based on the killer phenomenon. 211
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 136
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 136
Antibacterial effects of two synthetic peptides against Enterococcus faecalis biofilms: A preliminary in vitro study 122
L’antibiogramma per i miceti 119
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 114
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 114
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 113
Candidacidal activity of a novel killer toxin from Wickerhamomyces anomalus against fluconazole-susceptible and -resistant strains 113
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 109
Activity of two antimicrobial peptides against Enterococcus faecalis in a model of biofilm-mediated endodontic infection 109
Antibodies as a source of anti-infective peptides: an update 106
Antifungal peptides within the antibodies 106
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 103
Metabolic profiling of Candida albicans 103
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 101
Antimicrobial peptide L18R displays a modulating action against inter-kingdom biofilms in the Lubbock chronic wound biofilm model 100
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 98
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 98
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 97
A synthetic peptide as a novel anticryptococcal agent 96
Fungicidal activity of peptides encoded by immunoglobulin genes 96
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BIOFILMS WITH DIFFERENT WAVELENGTHS AND DYES WITH SYNTHETIC KILLER DECAPEPTIDE 96
Antibody peptide based antifungal immunotherapy 94
Antibody-mediated protective immunity in fungal infections 94
Detection of Mycobacterium bovis in bovine tissue samples by the Abbott LCx Mycobacterium tuberculosis assay and comparison with culture methods 93
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 93
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 91
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 91
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 90
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 90
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 89
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 88
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 88
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 88
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 87
Peptides from the inside of the antibodies are active against infectious agents and tumours 87
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 86
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 86
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 85
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 84
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 84
Natural and synthetic peptides with antifungal activity 84
Anaerobic yeast killer system. 83
Antifungal activity of the C-terminal peptide from human serum albumin 83
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 83
Antimicrobial effect on candida albicans biofilm bapplication of different wavelengths and dyes and the synthetic killer decapeptide KP 83
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 83
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 83
Novel Arginine- and Proline-Rich Candidacidal Peptides Obtained through a Bioinformatic Approach 82
Anticorpi immagini interne di tossine killer 82
Wickerhamomyces yeast killer toxins’ medical applications 82
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 81
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 80
Antireceptor yeast killer toxin-like antibiobodies 80
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 80
Metabolic profile of Candida albicans 80
Antibiobodies: antibiotic internal image antibodies 79
Antibodies as Crypts of Antiinfective and Antitumor Peptides 79
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 79
Innate antimicrobial and antiviral activities of antibody peptides 79
Antibiobodies: antibiotic-like antiidiotypic antibodies. 78
Metabolic Plasticity of Candida albicans in Response to Different Environmental Conditions 78
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 77
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 76
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 75
Nuovo modello di vaccinazione idiotipica e terapia anti-idiotipica nella candidosi sistemica 75
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 75
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 75
Mode of action of a killer peptide against Toxoplasma gondii 75
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 75
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 74
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 73
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 73
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 73
Immagine interna del fenomeno killer dei lieviti 73
Any antibody fragment might exert antifungal activity 73
Allergic bronchopulmonary aspergillosis: An important cause of asthma which is sometimes ignored 73
Yeast killer toxins and dimorphism. 72
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. 72
Marcatori epidemiologici. 71
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 71
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 71
Human natural yeast killer toxin-like antibodies 70
Valutazione del "Bacto INH Test Strips" per la determinazione della produzione di niacina nei micobatteri. 70
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 70
Candidacidal properties of peptides encoded by immunoglobulin genes 70
Mycobacterium parmense sp. nov 69
Protective antifungal yeast killer toxin-like antibodies 69
Biotipizzazione di microorganismi patogeni mediante il sistema killer dei lieviti. 69
Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans. 69
The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action 69
In vitro and in vivo anticandidal activity of killer peptide derivatives 69
Guideline for the analysis of the microbial communities of the human upper airways 68
Principi di micologia generale e tassonomia 68
Antimicrobial photodynamic therapy protocols on streptococcus mutans with different combinations of wavelengths and photosensitizing dyes 68
Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants 68
Production of yeast killer toxin in experimentally infected animals 67
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 67
Automazione dell’antibiogramma diretto sulle urine. 67
Totale 8.624
Categoria #
all - tutte 68.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020280 0 0 0 0 0 0 0 0 0 0 71 209
2020/20211.560 24 212 157 25 241 40 212 22 303 42 226 56
2021/20221.306 31 6 24 59 58 68 169 221 51 128 64 427
2022/20234.045 504 352 216 259 539 456 35 235 1.311 12 92 34
2023/20241.363 79 147 48 55 132 381 59 77 25 90 113 157
2024/20253.508 52 303 317 334 357 517 149 197 788 485 9 0
Totale 16.949